Beijing HOPE Pharmaceutical Co., Ltd.
Beijing HOPE Pharmaceutical Co., Ltd. (stock number 836438), founded in 2005 and located in Beijing Economic and technological development Zone. It is a high-tech enterprise focused on research and development of chemical drug . Hope got self-support imp & exp rights, dedicated to R&D, manufacture, sales and technology transfer service of APIs, intermediates and preparations.
Hope owns a high-level R&D team and has established a strict scientific research management system and a diversified service system. Through years of technical accumulation and steady development, Hope has been named as “National High-tech Enterprise” and “Beijing Science and Technology Research and Development Organization”.
Since its foundation, Hope has adhered to the policy of “taking technology as the core and talents as the foundation", invested in R&D in various fields such as anti-tumor drugs, psychoneurosis drugs, cardiovascular and cerebrovascular drugs, digestive system drugs and respiratory system drugs, achieved a number of achievements, applied for more than 10 invention patents, acquired more than 10 new drug certificates and production licenses, and more than 40 clinical lienses.
Hope takes "creating high-quality products and technologies" as its tenet and "improving the health and quality of human beings" as its mission, contributing to the pharmaceutical industry and human life. At the same time, it adheres to the concept of "adhering to corporate integrity management". "Fully meeting customer requirements" as the standard, continue to maintain the company's long-term steady development.